<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335752">
  <stage>Registered</stage>
  <submitdate>30/07/2010</submitdate>
  <approvaldate>2/08/2010</approvaldate>
  <actrnumber>ACTRN12610000633088</actrnumber>
  <trial_identification>
    <studytitle>The Australian Placental Transfusion Study (APTS): Should very pre term babies receive a placental blood transfusion at birth via deferring cord clamping versus standard cord clamping procedures?</studytitle>
    <scientifictitle>A randomised two arm open label controlled trial comparing standard immediate cord clamping versus deferring cord clamping for 60 seconds or more in babies born less than 30 weeks of gestation to determine which cord clamping method results in improved survival and less disability.</scientifictitle>
    <utrn />
    <trialacronym>APTS</trialacronym>
    <secondaryid>NCT02606058 </secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Pre term birth</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Complications of newborn</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Fetal medicine and complications of pregnancy</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Childbirth and postnatal care</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The intervention involves deferring clamping of the cord after birth. The obstetrician or midwife holds the baby as low as possible below the level of the placenta for 60 seconds or more and then clamps the cord 6 cm from the about 6 cm from the umbilicus.</interventions>
    <comparator>Immediate cord clamping (where the cord is clamped 6 cm from the umbilicus within 10 seconds of the delivery of the baby).</comparator>
    <control>Active</control>
    <interventioncode>Other interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Composite death and/or major morbidity at 36 completed weeks post menstrual age. Morbidity is defined by one or more of the following: brain injury on ultrasound, severe retinopathy, necrotising enterocolitis, late onset sepsis.</outcome>
      <timepoint>36 completed weeks post menstrual age</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>The death component of the composite primary outcome</outcome>
      <timepoint>36 completed weeks post menstrual age</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Major morbidity (incidence of one or more of brain injury on ultrasound, severe retinopathy, necrotising enterocolitis or late onset sepsis).</outcome>
      <timepoint>36 completed weeks post menstrual age</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Death or major disability (for example cerebral palsy with inability to walk; blindness; deafness; major problems with language or speech; ASQ score indicative of developmental delay)</outcome>
      <timepoint>up to 3 years corrected age</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Death or brain injury on ultrasound</outcome>
      <timepoint>36 completed weeks post menstrual age</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Death up to 3 years corrected age</outcome>
      <timepoint>Up to 3 years corrected age</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Major disability defined as cerebral palsy with an inability to walk unassisted, severe visual loss, deafness, major problems with language or speech, or a score indicative of developmental delay on Ages and Stages Questionnaire.</outcome>
      <timepoint>Up to 3 years corrected age</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Brain injury on ultrasound</outcome>
      <timepoint>36 completed weeks post menstrual age</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>IVH (all grades) seen on ultrasound </outcome>
      <timepoint>36 completed weeks post menstrual age</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>IVH (Grades 3 &amp; 4) seen on ultrasound</outcome>
      <timepoint>36 completed weeks post menstrual age</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>IVH (Grade 4) seen on ultrasound</outcome>
      <timepoint>36 completed weeks post menstrual age</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Severe retinopathy warranting treatment or Stage 4 retinopathy according to the Australian and New Zealand Neonatal Network (ANZNN) definitions</outcome>
      <timepoint>36 completed weeks post menstrual age</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Necrotizing enterocolitis with the following signs: at least 1 systemic sign, profile consistent with definite NEC, warranted treatment for NEC.</outcome>
      <timepoint>36 completed weeks post menstrual age</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Patent ductus arteriosis requiring treatment (documented in medical records)</outcome>
      <timepoint>36 completed weeks post menstrual age</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Chronic lung disease, defined as receiving supplemental oxygen or any form of assisted ventilation at 36 completed weeks post menstrual age for 4 consecutive hours in a 24 hour period</outcome>
      <timepoint>36 completed weeks post menstrual age</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Late onset sepsis, defined as a clinical picture consistent with sepsis, and either a positive culture of blood and/or CSF, or a positive urine culture by sterile collection, and at least 5 days of antibiotic treatment.</outcome>
      <timepoint>36 completed weeks post menstrual age</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Women who have a reasonable chance of delivering less than 30 weeks of gestation. Informed consent has been recieved from the parent or guardian.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>No indication or contraindication to placental transfusion, in the view of mother or baby.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>All mothers considered by the attending team to have  reasonable chance of dleivering before 30 weeks will be approached for consent. Randomisation and treatment allocation will be completed by a member of the obstetric, neonatal or midwifery team. Central phone randomisation will be used. This is a computerised interactive voice response system.</concealment>
    <sequence>Randomisation will be performed using an interactive voice response system built by an independent study statistician at the NHMRC Clinical Trials Centre, University of Sydney. All data will be stored securely by the statistical group at the centre.</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>24/09/2010</anticipatedstartdate>
    <actualstartdate>8/12/2010</actualstartdate>
    <anticipatedenddate />
    <actualenddate>6/01/2017</actualenddate>
    <samplesize>1600</samplesize>
    <actualsamplesize>1637</actualsamplesize>
    <recruitmentstatus>Active, not recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>19/04/2018</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia,Outside</recruitmentcountry>
    <recruitmentstate>ACT,NSW,QLD,SA,WA,VIC</recruitmentstate>
    <hospital>The Canberra Hospital - Garran</hospital>
    <hospital>Royal Prince Alfred Hospital - Camperdown</hospital>
    <hospital>Royal North Shore Hospital - St Leonards</hospital>
    <hospital>John Hunter Hospital Royal Newcastle Centre - New Lambton</hospital>
    <hospital>Liverpool Hospital - Liverpool</hospital>
    <hospital>Royal Hospital for Women - Randwick</hospital>
    <hospital>Nepean Hospital - Kingswood</hospital>
    <hospital>Monash Medical Centre - Clayton campus - Clayton</hospital>
    <hospital>Mercy Hospital for Women - Heidelberg</hospital>
    <hospital>Royal Brisbane &amp; Womens Hospital - Herston</hospital>
    <hospital>Mater Mother's Hospital - South Brisbane</hospital>
    <hospital>The Townsville Hospital - Douglas</hospital>
    <hospital>Flinders Medical Centre - Bedford Park</hospital>
    <hospital>King Edward Memorial Hospital - Subiaco</hospital>
    <postcode>2065</postcode>
    <postcode>2050</postcode>
    <postcode>2031</postcode>
    <postcode>2605</postcode>
    <postcode>3168</postcode>
    <postcode>3084</postcode>
    <postcode>4029</postcode>
    <postcode>5042</postcode>
    <postcode>6008</postcode>
    <postcode>2305 - New Lambton</postcode>
    <postcode>2170 - Liverpool</postcode>
    <postcode>2747 - Kingswood</postcode>
    <postcode>4101 - South Brisbane</postcode>
    <postcode>4814 - Douglas</postcode>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland, Christchurch, Dunedin, Waikato, Wellington</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Northern Ireland</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Pakistan</country>
      <state>Karachi</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Paris</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States of America</country>
      <state>Vermont; Texas</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Nova Scotia</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Sydney</primarysponsorname>
    <primarysponsoraddress>Locked Bag 77 Camperdown NSW 1450</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>National Health and Medical Research Council (NHMRC) project grant</fundingname>
      <fundingaddress>GPO Box 1421 Canberra ACT 2601</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Most preterm babies have the umbilical cord clamped within 10 seconds of birth. Placental transfusion is a simple way of giving the baby extra blood at birth by delaying the clamping of the umbilical cord by 60 seconds or more. There is promising evidence from randomised trials that placental transfusion in babies less than 37 weeks of pregnancy may improve their blood pressure, reduce the number of blood transfusions needed and decrease bleeding into the brain, bowel disease and infection. However, we not know if babies born before 30 weeks of pregnancy benefit or if placental transfusion increases or decreases death or childhood disability. Despite this uncertainty more doctors are recommending that all very preterm babies are given a placental transfusion at birth. It is important to find out if placental transfusion does more good than harm, before it becomes even more widely used. 

The Australian Placental Transfusion Study will enrol at least 1600 women who will give birth to babies born less than 30 weeks of gestation. These participants will be randomly assigned to either standard treatment where the umbilical cord is clamped within 10 seconds of birth or a second method where the umbilical cord will be clamped after waiting for 60 seconds or more at birth while the baby is being held below the level of the placenta. The main research question is whether placental transfusion reduces death and disability when the baby is discharged from hospital and into childhood.</summary>
    <trialwebsite>http://www.ctc.usyd.edu.au/public-trial-pages/apts.aspx</trialwebsite>
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Northern Sydney Central Coast</ethicname>
      <ethicaddress>Level 2, Building 51 Royal North Shore Hospital St Leonards NSW 2065</ethicaddress>
      <ethicapprovaldate>13/10/2010</ethicapprovaldate>
      <hrec>HREC/10/HAWKE/94 (1007-272M)</hrec>
      <ethicsubmitdate>21/07/2010</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Children's Health Queensland Hospital and Health Service HREC</ethicname>
      <ethicaddress>Human Research Ethics Committee
Level 7, Centre for Childrens Health Research
Lady Cilento Childrens Hospital Precinct
62 Graham Street
South Brisbane QLD 4101</ethicaddress>
      <ethicapprovaldate>29/04/2011</ethicapprovaldate>
      <hrec>HREC/11/QRCH/12</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Southern Health HREC B</ethicname>
      <ethicaddress>Research Directorate, Southern Health
Monash Medical Centre
246 Clayton Rd, Clayton VIC 3168</ethicaddress>
      <ethicapprovaldate>6/05/2011</ethicapprovaldate>
      <hrec>HREC/11/SHB/3 (11031B)</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Northern B Health and Disability Ethics Committee</ethicname>
      <ethicaddress>Ministry of Health, Freyberg Building
20 Aitken St, PO Box 5013
Wellington, 6011</ethicaddress>
      <ethicapprovaldate>13/03/2012</ethicapprovaldate>
      <hrec>MEC/11/12/102</hrec>
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Mercy Health HREC</ethicname>
      <ethicaddress>c/- Mercy Hospital for Women
Floor 6, Administration, 163 Studley Rd,
Heidelberg, VIC 3084</ethicaddress>
      <ethicapprovaldate>17/05/2011</ethicapprovaldate>
      <hrec>R11/16</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>ACT Health HREC</ethicname>
      <ethicaddress>Building 10, Level 6, ACT Health Research Office
Canberra Hospital, ACT 2605</ethicaddress>
      <ethicapprovaldate>1/06/2011</ethicapprovaldate>
      <hrec>ETH. 3.11.049</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>WNHS Human Research Ethics Committee</ethicname>
      <ethicaddress>King Edward Memorial Hospital
O Block
Entrance off Hensman Rd
Subiaco, Perth,
WA 6904</ethicaddress>
      <ethicapprovaldate>6/05/2011</ethicapprovaldate>
      <hrec>1879/EW</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Southern Adelaide Clinical HREC</ethicname>
      <ethicaddress>The Flats, F6/F8
Flinders Medical Centre
Flinders Drive, Bedford Park SA 5042</ethicaddress>
      <ethicapprovaldate>5/04/2011</ethicapprovaldate>
      <hrec>006.11</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>CPP Ile de France XI Comite de Protection des Personnes</ethicname>
      <ethicaddress>Pavillon Jacques Courtois - 2eme etage, 20 rue Armagis, 78105 Saint Germain-en-Laye Cedex</ethicaddress>
      <ethicapprovaldate>25/07/2014</ethicapprovaldate>
      <hrec>14052</hrec>
      <ethicsubmitdate />
      <ethiccountry>France</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Baylor College of Medicine IRB</ethicname>
      <ethicaddress>Office of Research
One Baylor Plaza, 600D
Houston, Texas 77030</ethicaddress>
      <ethicapprovaldate>14/11/2014</ethicapprovaldate>
      <hrec>H-34236</hrec>
      <ethicsubmitdate />
      <ethiccountry>United States of America</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>University of Vermont Committee on Human Subjects</ethicname>
      <ethicaddress>Research Protections Office
213 Waterman Building
85 South Prospect St
Burlington, Vermont 05405</ethicaddress>
      <ethicapprovaldate>1/07/2014</ethicapprovaldate>
      <hrec>CHRMS: 14-536</hrec>
      <ethicsubmitdate />
      <ethiccountry>United States of America</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>IWK Health Centre Research Ethics Board</ethicname>
      <ethicaddress>IWK Health Centre - Research
5850/5980 University Ave
PO Box 9700, Halifax
Nova Scotia B3K 6R8</ethicaddress>
      <ethicapprovaldate>11/12/2015</ethicapprovaldate>
      <hrec>1018451</hrec>
      <ethicsubmitdate />
      <ethiccountry>Canada</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Aga Khan Univesity Ethical Review Committee</ethicname>
      <ethicaddress>Stadium Rd, PO Box 3500
Karachi 74800</ethicaddress>
      <ethicapprovaldate>3/05/2013</ethicapprovaldate>
      <hrec>2451-Obs-ERC-13</hrec>
      <ethicsubmitdate />
      <ethiccountry>Pakistan</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Professor William Tarnow-Mordi</name>
      <address>Locked Bag 77
Camperdown NSW 1450</address>
      <phone>+ 61 2 9562 5062</phone>
      <fax>+ 61 2 9565 1863</fax>
      <email>Williamtm@med.usyd.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>APTS Trial Coordinator</name>
      <address>Locked Bag 77
Camperdown NSW 1450</address>
      <phone>+61 2 9562 5000</phone>
      <fax>+61 2 9565 1863</fax>
      <email>apts@ctc.usyd.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>APTS Trial Coordinator</name>
      <address>Locked Bag 77
Camperdown NSW 1450</address>
      <phone>+ 61 2 9562 5000</phone>
      <fax>+ 61 2 9562 1863</fax>
      <email>apts@ctc.usyd.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>William Tarnow Mordi</name>
      <address>NHMRC Clinical Trials Centre
Locked Bag 77
Camperdown NSW 1450</address>
      <phone>+6129562 5000</phone>
      <fax />
      <email>williamtm@med.usyd.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>